Publicaciones en colaboración con investigadores/as de Instituto Valenciano de Oncologia (2)

2019

  1. Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

    Clinical Colorectal Cancer, Vol. 18, Núm. 3, pp. 183-191.e3

2016

  1. Aflibercept plus FOLFIRI for 2nd line treatment of metastatic colorectal cancer (mCRC): Long-term safety observation from the global aflibercept safety and quality-of-life (QoL) program (ASQoP)

    Annals of Oncology, Vol. 27, pp. vi182